These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27408792)

  • 21. Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy.
    Wang L; Benzinger TL; Su Y; Christensen J; Friedrichsen K; Aldea P; McConathy J; Cairns NJ; Fagan AM; Morris JC; Ances BM
    JAMA Neurol; 2016 Sep; 73(9):1070-7. PubMed ID: 27454922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease.
    Wang L; Benzinger TL; Hassenstab J; Blazey T; Owen C; Liu J; Fagan AM; Morris JC; Ances BM
    Neurology; 2015 Mar; 84(12):1254-60. PubMed ID: 25716355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals.
    d'Oleire Uquillas F; Jacobs HIL; Hanseeuw B; Marshall GA; Properzi M; Schultz AP; LaPoint MR; Johnson KA; Sperling RA; Vannini P
    Neuroimage Clin; 2018; 17():388-396. PubMed ID: 29159051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
    Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
    Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.
    Kim CM; Hwang J; Lee JM; Roh JH; Lee JH; Koh JY;
    Curr Alzheimer Res; 2015; 12(6):563-71. PubMed ID: 26027813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain amyloid-β burden is associated with disruption of intrinsic functional connectivity within the medial temporal lobe in cognitively normal elderly.
    Song Z; Insel PS; Buckley S; Yohannes S; Mezher A; Simonson A; Wilkins S; Tosun D; Mueller S; Kramer JH; Miller BL; Weiner MW
    J Neurosci; 2015 Feb; 35(7):3240-7. PubMed ID: 25698758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex.
    Sepulcre J; Grothe MJ; Sabuncu M; Chhatwal J; Schultz AP; Hanseeuw B; El Fakhri G; Sperling R; Johnson KA
    JAMA Neurol; 2017 Jul; 74(7):813-820. PubMed ID: 28558094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced Repetition Suppression in Aging is Driven by Tau-Related Hyperactivity in Medial Temporal Lobe.
    Adams JN; Maass A; Berron D; Harrison TM; Baker SL; Thomas WP; Stanfill M; Jagust WJ
    J Neurosci; 2021 Apr; 41(17):3917-3931. PubMed ID: 33731446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals.
    Lim YY; Williamson R; Laws SM; Villemagne VL; Bourgeat P; Fowler C; Rainey-Smith S; Salvado O; Martins RN; Rowe CC; Masters CL; Maruff P;
    J Alzheimers Dis; 2017; 58(4):1293-1302. PubMed ID: 28550258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
    Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
    Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Entorhinal-Hippocampal Circuit Integrity Is Related to Mnemonic Discrimination and Amyloid-β Pathology in Older Adults.
    Adams JN; Kim S; Rizvi B; Sathishkumar M; Taylor L; Harris AL; Mikhail A; Keator DB; McMillan L; Yassa MA
    J Neurosci; 2022 Nov; 42(46):8742-8753. PubMed ID: 36302636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid-β associated cortical thinning in clinically normal elderly.
    Becker JA; Hedden T; Carmasin J; Maye J; Rentz DM; Putcha D; Fischl B; Greve DN; Marshall GA; Salloway S; Marks D; Buckner RL; Sperling RA; Johnson KA
    Ann Neurol; 2011 Jun; 69(6):1032-42. PubMed ID: 21437929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Pre-Clinical AD Small Vessel Disease is Associated With Altered Hippocampal Connectivity and Atrophy.
    Wu M; Schweitzer N; Iordanova BE; Halligan-Eddy E; Tudorascu DL; Mathis CA; Lopresti BJ; Kamboh MI; Cohen AD; Snitz BE; Klunk WE; Aizenstein HJ
    Am J Geriatr Psychiatry; 2023 Feb; 31(2):112-123. PubMed ID: 36274019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline.
    Hanseeuw BJ; Betensky RA; Schultz AP; Papp KV; Mormino EC; Sepulcre J; Bark JS; Cosio DM; LaPoint M; Chhatwal JP; Rentz DM; Sperling RA; Johnson KA
    Ann Neurol; 2017 Apr; 81(4):583-596. PubMed ID: 28253546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults.
    Scott MR; Hampton OL; Buckley RF; Chhatwal JP; Hanseeuw BJ; Jacobs HI; Properzi MJ; Sanchez JS; Johnson KA; Sperling RA; Schultz AP
    Neuroimage; 2020 Oct; 220():116991. PubMed ID: 32512123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing beta-amyloid deposition in cognitively healthy aging predicts nonlinear change in BOLD modulation to difficulty.
    Kennedy KM; Foster CM; Rodrigue KM
    Neuroimage; 2018 Dec; 183():142-149. PubMed ID: 30102997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cortical thickness, brain metabolic activity, and in vivo amyloid deposition in asymptomatic, middle-aged offspring of patients with late-onset Alzheimer's disease.
    Duarte-Abritta B; Villarreal MF; Abulafia C; Loewenstein D; Curiel Cid RE; Castro MN; Surace E; Sánchez SM; Vigo DE; Vázquez S; Nemeroff CB; Sevlever G; Guinjoan SM
    J Psychiatr Res; 2018 Dec; 107():11-18. PubMed ID: 30308328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.
    Khan W; Giampietro V; Banaschewski T; Barker GJ; Bokde AL; Büchel C; Conrod P; Flor H; Frouin V; Garavan H; Gowland P; Heinz A; Ittermann B; Lemaître H; Nees F; Paus T; Pausova Z; Rietschel M; Smolka MN; Ströhle A; Gallinat J; Vellas B; Soininen H; Kloszewska I; Tsolaki M; Mecocci P; Spenger C; Villemagne VL; Masters CL; Muehlboeck JS; Bäckman L; Fratiglioni L; Kalpouzos G; Wahlund LO; Schumann G; Lovestone S; Williams SC; Westman E; Simmons A; ; ;
    J Alzheimers Dis; 2017; 56(3):1159-1174. PubMed ID: 28157104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.